Smell in Covid-19 and Efficacy of Nasal Theophylline

NCT04789499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Anosmia
Olfactory Disorder
Covid-19 Pandemic
SARS-CoV-2 Infection
Hyposmia
Ageusia
Hypogeusia

Interventions

DRUG: Theophylline Powder
DRUG: Placebo Comparator

Sponsor

Washington University School of Medicine